Moulton, AL, United States of America

Tony Drew Vinson

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Nektar Therapeutics. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tony Drew Vinson. Retrieved from https://idiyas.com/inventor/tony-drew-vinson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Tony Drew Vinson

Introduction

Tony Drew Vinson is a notable inventor based in Moulton, Alabama, who has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Vinson's work focuses on enhancing the efficacy of existing compounds through innovative conjugation techniques.

Latest Patents

Among his latest patents, Vinson has developed polymer-sunitinib conjugates. This invention relates to polymer-sunitinib conjugates and related compounds. A compound of this invention, when administered by various routes, exhibits advantages over sunitinib in its unconjugated form. This advancement has the potential to improve therapeutic outcomes for patients.

Career Highlights

Vinson is currently associated with Nektar Therapeutics, a company known for its commitment to developing innovative therapies. His work at Nektar Therapeutics has allowed him to explore new avenues in drug development and delivery systems.

Collaborations

Throughout his career, Vinson has collaborated with talented individuals such as Sean M Culbertson and Antoni Kozlowski. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise.

Conclusion

Tony Drew Vinson's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in drug therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…